Search by Drug Name or NDC
NDC 59088-0795-54 Folcyteine 200; 47; 800; 1000; 16 mg/1; mg/1; [iU]/1; ug/1; mg/1 Details
Folcyteine 200; 47; 800; 1000; 16 mg/1; mg/1; [iU]/1; ug/1; mg/1
Folcyteine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PureTek Corporation. The primary component is ACETYLCYSTEINE; CALCIUM CITRATE; CHOLECALCIFEROL; FOLIC ACID; MAGNESIUM CITRATE.
Product Information
| NDC | 59088-0795 |
|---|---|
| Product ID | 59088-795_04cf0026-e299-ffd5-e063-6294a90aca1f |
| Associated GPIs | |
| GCN Sequence Number | 085352 |
| GCN Sequence Number Description | folic/calcium/D3/Mg cit/a-cyst TABLET 1 MG-47 MG ORAL |
| HIC3 | C6M |
| HIC3 Description | FOLIC ACID PREPARATIONS |
| GCN | 54811 |
| HICL Sequence Number | 045858 |
| HICL Sequence Number Description | FOLIC ACID/CALCIUM CITRATE/VITAMIN D3/MAG CITRATE/A-CYSTEINE |
| Brand/Generic | Brand |
| Proprietary Name | Folcyteine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Multivitamin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200; 47; 800; 1000; 16 |
| Active Ingredient Units | mg/1; mg/1; [iU]/1; ug/1; mg/1 |
| Substance Name | ACETYLCYSTEINE; CALCIUM CITRATE; CHOLECALCIFEROL; FOLIC ACID; MAGNESIUM CITRATE |
| Labeler Name | PureTek Corporation |
| Pharmaceutical Class | Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Decreased Respiratory Secretion Viscosity [PE], Increased Coagulation Factor Activity [PE], I |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59088-0795-54 (59088079554)
| NDC Package Code | 59088-795-54 |
|---|---|
| Billing NDC | 59088079554 |
| Package | 30 TABLET in 1 BOTTLE, PLASTIC (59088-795-54) |
| Marketing Start Date | 2023-09-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |